Indication & Safety Information

Thermi®‘s temperature controlled RF system is indicated:
• In the United States for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
• In Europe for electrocoagulation of soft tissues for vulvovaginal laxity.

Indication & Safety Information

Thermi® radiofrequency products should not be used on patients who are pregnant, have a fever or skin infection on or around the area of application. Expected procedure side effects may include transient pain in the procedure area, erythema, and edema.

Welcome

PLEASE SELECT YOUR LOCATION